| 000 | 01732 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511182111.0 | ||
| 264 | 0 | _c19920828 | |
| 008 | 199208s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/0006-8993(92)90812-n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMao, J | |
| 245 | 0 | 0 |
_aCalcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation. _h[electronic resource] |
| 260 |
_bBrain research _cMar 1992 |
||
| 300 |
_a157-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a2-Amino-5-phosphonovalerate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBombesin _xpharmacology |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xpharmacology |
| 650 | 0 | 4 | _aCatheterization |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aKainic Acid _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicroinjections |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidonecarboxylic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStrychnine _xpharmacology |
| 650 | 0 | 4 |
_aSubstance P _xanalogs & derivatives |
| 700 | 1 | _aCoghill, R C | |
| 700 | 1 | _aKellstein, D E | |
| 700 | 1 | _aFrenk, H | |
| 700 | 1 | _aMayer, D J | |
| 773 | 0 |
_tBrain research _gvol. 574 _gno. 1-2 _gp. 157-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-8993(92)90812-n _zAvailable from publisher's website |
| 999 |
_c1385600 _d1385600 |
||